Targeting the mammalian target of rapamycin pathway in neurological manifestations of Covid-19
Description
The diverse and severe nature of neurological manifestations associated with coronavirus disease 2019 (Covid-19) has garnered increasing attention. Exploring the potential to decrease neurological complications in Covid-19 patients involves targeting
